Summary:
Placebo-controlled, relapse prevention study with Vilazodone in patients With Major Depressive Disorder.
Qualified Participants Must:
• Be between 18 and 70 years of age
•
Currently meet the DSM-IV-TR criteria for Major Depressive Disorder
•
Have had a major depressive episode that was at least 8 weeks and no longer than 18 months in duration
Qualified Participants May Receive:
Compensation and free study related procedure, and free medication